Upadacitinib Hemihydrate

Records for this ingredient, by country (identity only).

ATC — · 5 markets · 14 records

Upadacitinib Hemihydrate 5 markets · 14 records Forms
Filters
MarketAU 4SG 3TW 3FR 3GB 1

AU 4 records · 3 shown of 3 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 46.1 mgtablet · extended-releaseRINVOQ upadacitinib 15 mg modified release tablet blister pack unknown
  • 30.7 mgtablet · extended-releaseRINVOQ upadacitinib 15 mg modified release tablet blister pack unknown
  • 15.4 mgtablet · extended-releaseRINVOQ upadacitinib 15 mg modified release tablet blister pack unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Rinvoq ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

SG 3 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

TW 3 records · 3 shown of 3 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

FR 3 records · 3 shown of 3 Source Base de données publique des médic · Data as of 2026-11-03

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.